drugset / Trial / NCT00217841
Aurograb and Vancomycin in MRSA Infection
RandomizedParallel-groupDouble-blindEct
Summary
The study hypothesis is that the addition of Aurograb to standard vancomycin therapy will improve outcome in MRSA infection.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aurograb | Unknown | 1 mg/kg | Intravenous |